Skip to content

Ansbert Gadicke, 10% owner at Entrada Therapeutics, sold TRDA on Aug 31, 2026

Data as of Oct 16

▼ SELL$309K44,259 shares at $6.99Ansbert Gadicke 10% ownerTRDA Entrada Therapeutics, Inc.
Watch TRDA
Traded
Aug 31, 2026
Disclosed
Aug 31, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Ansbert Gadicke, 10% owner at Entrada Therapeutics, sold TRDA on Aug 31, 2026TRADEDDISCLOSED
TRDASimilar stocks (XLV — its sector index fund), rebased to TRDA's price on the disclosure day
TRDA since disclosure
−38.0%
after the sale
Similar stocks (XLV) since disclosure
+3.6%
XLV — its sector index fund

Change in closing price from Aug 31, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLMPM BioVentures 2014, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$309Kdisclosed Aug 31 · filed the same day
  2. ▼ SELLMPM BioVentures 2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$309Kdisclosed Aug 31 · filed the same day
  3. ▼ SELLTodd Foley 10% ownerTRDA Entrada Therapeutics, Inc.$309Kdisclosed Aug 31 · filed the same day
  4. ▼ SELLLuke Evnin 10% ownerTRDA Entrada Therapeutics, Inc.$309Kdisclosed Aug 31 · filed the same day
  5. ▼ SELLMPM BioVentures 2014 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$309Kdisclosed Aug 31 · filed the same day
  6. ▼ SELLMPM BioVentures 2014 GP LLC 10% ownerTRDA Entrada Therapeutics, Inc.$309Kdisclosed Aug 31 · filed the same day
  7. ▼ SELLMpm Bioventures 2018 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$309Kdisclosed Aug 31 · filed the same day
  8. ▼ SELLMpm Asset Management Investors Bv2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$309Kdisclosed Aug 31 · filed the same day
  9. ▼ SELLMPM Asset Management Investors BV2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$309Kdisclosed Aug 31 · filed the same day
  10. ▼ SELLMPM Asset Management Investors BV2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$26.2Kdisclosed Aug 31 · filed 3 days after the trade
  11. ▼ SELLMPM BioVentures 2014, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$26.2Kdisclosed Aug 31 · filed 3 days after the trade
  12. ▼ SELLMPM BioVentures 2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$26.2Kdisclosed Aug 31 · filed 3 days after the trade
  13. ▼ SELLAnsbert Gadicke 10% ownerTRDA Entrada Therapeutics, Inc.$26.2Kdisclosed Aug 31 · filed 3 days after the trade
  14. ▼ SELLMPM BioVentures 2014 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$26.2Kdisclosed Aug 31 · filed 3 days after the trade
  15. ▼ SELLMpm Bioventures 2018 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$26.2Kdisclosed Aug 31 · filed 3 days after the trade

See every trade on TRDA →